Low Lymphocyte Ratio as a Novel Prognostic Factor in Acute Heart Failure: Results from the Pre-RELAX-AHF Study

Olga Milo-Cotter*, John R. Teerlink, Marco Metra, G. Michael Felker, Piotr Ponikowski, Adriaan A. Voors, Christopher Edwards, Beth Davison Weatherley, Barry Greenberg, Gerassimos Filippatos, Elaine Unemori, Sam L. Teichman, Gad Cotter

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)

Abstract

Background: Previous studies have suggested that a lower lymphocyte ratio (Ly%) in the white blood cell (WBC) differential count is related to worse outcomes in patients with acute heart failure (AHF) and other cardiovascular disorders. Methods: In the Pre-RELAX-AHF study, 234 patients with AHF, systolic blood pressure >125 mm Hg and brain natriuretic peptide >= 350 pg/ml or equivalent were randomized to 1 of 4 intravenous doses of relaxin or placebo and followed up for 6 months following randomization. Complete blood count and differential were performed by a central laboratory at baseline and then daily to day 5 and on day 14. Results: The WBC count by itself was not associated with measures of disease severity or outcome, and patients with Ly% 13%, except for a higher baseline WBC count, elevated baseline glucose, older age and higher rates of peripheral vascular disease. However, patients with Ly%

Original languageEnglish
Pages (from-to)190-196
Number of pages7
JournalCardiology
Volume117
Issue number3
DOIs
Publication statusPublished - 2010

Keywords

  • White blood cells
  • Lymphocytes
  • Heart failure
  • COUNT
  • MORTALITY
  • TRANSPLANT
  • APOPTOSIS
  • SURVIVAL
  • DEATH
  • RISK

Fingerprint

Dive into the research topics of 'Low Lymphocyte Ratio as a Novel Prognostic Factor in Acute Heart Failure: Results from the Pre-RELAX-AHF Study'. Together they form a unique fingerprint.

Cite this